C4 Therapeutics
CCCC
CCCC
113 hedge funds and large institutions have $232M invested in C4 Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 29
37% less capital invested
Capital invested by funds: $366M → $232M (-$134M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
113
Holding in Top 10
1
Calls
$2.35M
Puts
$425K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$5.45M | |
| 3 | +$3.71M | |
| 4 |
BlackRock
New York
|
+$2.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.53M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$5.7M | |
| 3 | -$3.62M | |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$1.52M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.29M |